84 related articles for article (PubMed ID: 15059346)
1. [Inhibitory effects of antisense TGF beta1 on in vitro and in vivo proliferation of human bladder cancer cells].
Yao X; Chang JW; Li WL; Niu RF; Sun BC; Ma TX
Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):18-21. PubMed ID: 15059346
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibiting effects of antisense eukaryotic expression vector of proliferating cell nuclear antigen gene on human bladder cancer cells.
Tong Q; Zeng F; Lin C; Zhao J; Lu G
Chin Med J (Engl); 2003 Aug; 116(8):1203-6. PubMed ID: 12935412
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotide specific for transforming growth factor-beta 1 inhibit both in vitro and in vivo growth of MBT-2 murine bladder cancer.
Tzai TS; Lin CI; Shiau AL; Wu CL
Anticancer Res; 1998; 18(3A):1585-9. PubMed ID: 9673374
[TBL] [Abstract][Full Text] [Related]
5. [Influence of transfection of sense- and antisense-TGF beta 1 gene on human pulmonary giant cell carcinoma cell proliferation].
Yang H; Lu Y; Shen H
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):89-92. PubMed ID: 10743067
[TBL] [Abstract][Full Text] [Related]
6. Micro-array analysis of the effect of post-transurethral bladder tumor resection urine on transforming growth factor-beta1 dependent gene expression in transitional cell carcinoma.
Zhang G; Cao Y; Xu Y; See WA
Urol Oncol; 2005; 23(6):413-8. PubMed ID: 16301119
[TBL] [Abstract][Full Text] [Related]
7. Expression of an antisense transforming growth factor-beta1 transgene reduces tumorigenicity of EMT6 mammary tumor cells.
Park JA; Wang E; Kurt RA; Schluter SF; Hersh EM; Akporiaye ET
Cancer Gene Ther; 1997; 4(1):42-50. PubMed ID: 9012450
[TBL] [Abstract][Full Text] [Related]
8. [Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1].
Guo W; Xu H; Huang WY; Chen J; Yang Y; Fu R; Liu HM; Zha XL; Zhang ZG
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1660-5. PubMed ID: 17825142
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivo.
Marzo AL; Fitzpatrick DR; Robinson BW; Scott B
Cancer Res; 1997 Aug; 57(15):3200-7. PubMed ID: 9242450
[TBL] [Abstract][Full Text] [Related]
10. Effects of transforming growth factor beta 1 on the growth of rhabdomyosarcoma cell line RD.
Ye L; Zhang HY; Wang H; Yang GH; Bu H; Zhang L; Wang SL
Chin Med J (Engl); 2005 Apr; 118(8):678-86. PubMed ID: 15899124
[TBL] [Abstract][Full Text] [Related]
11. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
12. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
13. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
14. [The effects of tamoxifen on human hepatocellular carcinoma cell proliferation and transforming growth factor-beta1 expression].
Shin JW; Chung YH; Park MI; Kim JA; Choi MH; Lee YJ; Ryu SH; Park NH; Lee HC; Lee YS; Suh DJ; Yu ES
Taehan Kan Hakhoe Chi; 2003 Mar; 9(1):10-6. PubMed ID: 12657824
[TBL] [Abstract][Full Text] [Related]
15. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
16. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
Yamamoto N; Imai J; Watanabe M; Hiroi N; Sugano S; Yoshino G
Horm Metab Res; 2006 Mar; 38(3):159-66. PubMed ID: 16673206
[TBL] [Abstract][Full Text] [Related]
17. Activin A inhibits growth-inhibitory signals by TGF-beta1 in differentiated human endometrial adenocarcinoma cells.
Tanaka T; Toujima S; Umesaki N
Oncol Rep; 2004 Apr; 11(4):875-9. PubMed ID: 15010888
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
[TBL] [Abstract][Full Text] [Related]
19. Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination.
Perry K; Wong L; Liu V; Park I; Zhang Q; Rejen V; Huang X; Smith ND; Jovanovic B; Lonning S; Teicher BA; Lee C
Urology; 2008 Jul; 72(1):225-9. PubMed ID: 18295867
[TBL] [Abstract][Full Text] [Related]
20. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
